Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • D.L. Dewi - (Author)
  • S.R. Mohapatra - (Author)
  • S. Blanco Cabañes - (Author)
  • I. Adam - (Author)
  • L.F. Somarribas Patterson - (Author)
  • B. Berdel - (Author)
  • M. Kahloon - (Author)
  • L. Thürmann - (Author)
  • S. Loth - (Author)
  • K. Heilmann - (Author)
  • D. Weichenhan - (Author)
  • O. Mücke - (Author)
  • I. Heiland - (Author)
  • P. Wimberger - , Department of Gynecology and Obstetrics (Author)
  • J.D. Kuhlmann - , Department of Gynecology and Obstetrics (Author)
  • K.H. Kellner - (Author)
  • S. Schott - (Author)
  • C. Plass - (Author)
  • M. Platten - (Author)
  • C. Gerhäuser - (Author)
  • S. Trump - (Author)
  • C.A. Opitz - (Author)

Details

Original languageEnglish
JournalOncoImmunology
Publication statusPublished - 2017
Peer-reviewedYes

External IDs

Scopus 85011844324

Keywords

Sustainable Development Goals